期刊文献+

疱疹病毒gD基因多聚核苷酸疫苗的构建和表达 被引量:8

Construction and Expression of Herpes Simplex Virus Glycoprotein Polynucleotide Vaccine
原文传递
导出
摘要 目的构建疱疹病毒 gD2基因多聚核苷酸疫苗并在实验动物中得到表达。方法将构建的 pcDNA3-gD2的质粒 DNA注射入豚鼠的舌肌中,每周 1次,共 3次,最后 1次免疫 48 h后引颈处死豚鼠,并取其舌、肝、脾、肾、心脏及股四头肌,用免疫组化法 (SP法 )检测 gD2抗原的表达。结果重组质粒组 gD2真核表达载体免疫接种后,均可在舌肌测到抗原表达,而对照组均为阴性。结论重组质粒 gD2真核表达载体可以在豚鼠舌肌中表达,对建立基因免疫防治疱疹病毒感染奠定一定基础。 Objective To construct Herpes simplex virus-2 glycoprotein D polynucleotide vaccine, and to detect the glycoprotein D2(gD2) expression in guinea pig′ s tongue by intramuscular injection of gD2 polynucleotide vaccine. Methods The recombinant plasmids HSV-gD2 polynucleotide vaccine was constructed by molecular cloning technique. The guniea pigs were intramuscularly injected with 0.75% bupivacaine, after 7 days, they were divided into 3 groups(4 guinea pigs per group) and intramuscularly injected with 100μ L 0.09% NaCl、 pcDNA3、 gD2-pcDNA3, three times at 7 day intervals respectively. All guinea pigs were sacrificed 2 days after the last injection, and the tongue, liver, kidney, spleen and quadricep muscle were removed for immunohistochemical assay (SP method). Results The recombinant pcDNA3-gD2 plasmid was constructed succuessfully. Immunohistochemical staining for gD2 was positive in the tongue injected with pcDNA3-gD2, but negative in the liver, kidney, spleen, heart and quadricep muscle. Conclusion Herpes simplex virus-2 glycoprotein D polynucleotide vaccine was constructed successfully, and gD2 antigen can be expressed effectively in the tongue after injection of the HSV-gD2 polynucleotide vaccine in it.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2001年第1期53-54,共2页 Chinese Journal of Dermatology
基金 广东省科委自然科学基金资助! (960671)
关键词 生殖器疱疹 糖蛋白D 多聚核苷酸疫苗 疱疹病毒 GD基因 重组质粒 Herpes, genitalis Glycoprotein D Polynucleotide vaccines
  • 相关文献

参考文献2

二级参考文献3

  • 1杨雄虎,病毒学报,1993年,4卷,309页
  • 2喻启桂,中华微生物学和免疫学杂志,1991年,4卷,212页
  • 3秦克锋,国外医学微生物学分册,1989年,4卷,149页

共引文献15

同被引文献32

  • 1刘仲荣,曹春来,杨慧兰,郭勇,王捷.全长单纯疱疹病毒Ⅱ型糖蛋白D毕赤酵母表达载体的构建[J].实用医学杂志,2005,21(11):1117-1119. 被引量:2
  • 2陈威巍,赫兢,辛绍杰.丙型肝炎病毒DNA疫苗的研究进展[J].医学研究生学报,2006,19(5):469-473. 被引量:4
  • 3Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization [ J ]. Annu Rev Immunol. 2005, 18 : 927 -74.
  • 4Liu MA. DNA vaccines: a review[J]. J Int Med, 2003, 253:402 -410.
  • 5Joseph E, Blaney JR. et al, Immunization with a Single Major Histocompatibility Complex Class I - Restricted Cytotoxic T - Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity [ J ]. Journal of Virology. 1998. Dec :9567 - 9574.
  • 6Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization [ J ]. Annu Rev Immuno, 2000, 18 (4) : 927 - 974.
  • 7Hasan UA, Abai AM, Harper DR, et al. Nucleic acid immunization: concepts and techniques associated with third generation vaccines [ J ]. J Immunol Methods, 1999, 229(1 -2) : 1 -22.
  • 8Seder RA, Gurunathan S. DNA vaccines - designer vaccines for the 21st century[J]. N Engl J Med, 1999, 341 (4) : 277 -278.
  • 9FDA. Points to consider on plasmid DNA vaccine for preventive infectious disease indications, 1996, Dec 22.
  • 10Steaus SE, Wald A, Kost RG et al. Immunotherapy of recurrent genital herpes with recombinant herpes virus type2 glycoprotein D and B ; results of placebo controlled [J]. Trial, J Infect DIS, 2002, 176:1129- 1134.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部